323 results on '"Van den Abbeele, Pieter"'
Search Results
52. Long-Term Lactulose Administration Improves Dysbiosis Induced by Antibiotic and C. difficile in the PathoGut TM SHIME Model.
53. A Cranberry Concentrate Decreases Adhesion and Invasion of Escherichia coli (AIEC) LF82 In Vitro
54. Chitin Glucan Shifts Luminal and Mucosal Microbial Communities, Improve Epithelial Barrier and Modulates Cytokine Production In Vitro
55. A Pectin-Rich, Baobab Fruit Pulp Powder Exerts Prebiotic Potential on the Human Gut Microbiome In Vitro
56. A randomized, placebo-controlled trial investigating the acute and chronic benefits of American Ginseng (Cereboost®) on mood and cognition in healthy young adults, including in vitro investigation of gut microbiota changes as a possible mechanism of action
57. 2′FL and LNnT Exert Antipathogenic Effects against C. difficile ATCC 9689 In Vitro, Coinciding with Increased Levels of Bifidobacteriaceae and/or Secondary Bile Acids
58. Comparative Effect of 22 Dietary Sources of Fiber on Gut Microbiota of Healthy Humans in vitro
59. Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25–3T studied in an in vitro gut model
60. Prebiotics, Faecal Transplants and Microbial Network Units to Stimulate Biodiversity of the Human Gut Microbiome
61. In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tract
62. Studying the host-microbiota interaction in the human gastrointestinal tract: basic concepts and in vitro approaches
63. Oats Containing 1.4g β-Glucan Significantly Increased Lactobacillus Levels In Vitro using M-SHIME® Model and In Vivo in Healthy Adults with Elevated Cholesterol Levels
64. Synthetic microbial ecosystems: an exciting tool to understand and apply microbial communities
65. In vitro model to study the modulation of the mucin-adhered bacterial community
66. impact of environmental pH on the gut microbiota community structure and short chain fatty acid production.
67. Antioxidant Vitamins and Prebiotic FOS and XOS Differentially Shift Microbiota Composition and Function and Improve Intestinal Epithelial Barrier In Vitro
68. Development of an Affordable, Sustainable and Efficacious Plant-Based Immunomodulatory Food Ingredient Based on Bell Pepper or Carrot RG-I Pectic Polysaccharides
69. A Comparison of the In Vitro Effects of 2’Fucosyllactose and Lactose on the Composition and Activity of Gut Microbiota from Infants and Toddlers
70. In vitro–in vivo Validation of Stimulatory Effect of Oat Ingredients on Lactobacilli
71. Fructans with Varying Degree of Polymerization Enhance the Selective Growth of Bifidobacterium animalis subsp. lactis BB-12 in the Human Gut Microbiome In Vitro
72. Intestinal colonization: How key microbial players become established in this dynamic process: Microbial metabolic activities and the interplay between the host and microbes
73. Development and validation of the simulator of the Canine Intestinal Microbial Ecosystem (SCIME)
74. Comparison of the Bifidogenic Effects of Goat and Cow Milk-Based Infant Formulas to Human Breast Milk in an in vitro Gut Model for 3-Month-Old Infants
75. The impact of the Fungus-Host-Microbiota interplay uponCandida albicansinfections: current knowledge and new perspectives
76. Comparison of the effects of soluble corn fiber and fructooligosaccharides on metabolism, inflammation, and gut microbiome of high-fat diet-fed mice
77. Evaluation of the Anti-Adhesive Effect of Milk Fat Globule Membrane Glycoproteins on Helicobacter pylori in the Human NCI-N87 Cell Line and C57BL/6 Mouse Model
78. Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus
79. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats
80. Synbiotic Effect of Bifidobacterium lactis CNCM I-3446 and Bovine Milk-Derived Oligosaccharides on Infant Gut Microbiota
81. Bacillus subtilis HU58 and Bacillus coagulans SC208 Probiotics Reduced the Effects of Antibiotic-Induced Gut Microbiome Dysbiosis in an M-SHIME® Model
82. A Novel Non-Digestible, Carrot-Derived Polysaccharide (cRG-I) Selectively Modulates the Human Gut Microbiota while Promoting Gut Barrier Integrity: An Integrated In Vitro Approach
83. Dried yeast cell walls high in beta-glucan and mannan-oligosaccharides positively affect microbial composition and activity in the canine gastrointestinal tract in vitro
84. In Vitro Evaluation of Prebiotic Properties of a Commercial Artichoke Inflorescence Extract Revealed Bifidogenic Effects
85. Fate and Bioaccessibility of Iodine in Food Prepared from Agronomically Biofortified Wheat and Rice and Impact of Cofertilization with Zinc and Selenium
86. Yeast-Derived Formulations Are Differentially Fermented by the Canine and Feline Microbiome As Assessed in a Novel In Vitro Colonic Fermentation Model
87. Development and validation of the Simulator of the Canine Intestinal Microbial Ecosystem (SCIME)1
88. Metabolic Analysis of Regionally Distinct Gut Microbial Communities Using an In Vitro Platform
89. Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
90. A four-strain probiotic exerts positive immunomodulatory effects by enhancing colonic butyrate production in vitro
91. Different Oat Ingredients Stimulate Specific Microbial Metabolites in the Gut Microbiome of Three Human Individuals in Vitro
92. Metabolic Analysis of Regionally Distinct Gut Microbial Communities Using an In Vitro Platform.
93. Establishing a mucosal gut microbial community in vitro using an artificial simulator
94. Complementary Mechanisms for Degradation of Inulin-Type Fructans and Arabinoxylan Oligosaccharides among Bifidobacterial Strains Suggest Bacterial Cooperation
95. Arabinoxylo-Oligosaccharides and Inulin Impact Inter-Individual Variation on Microbial Metabolism and Composition, Which Immunomodulates Human Cells
96. Yeast-Derived Formulations Are Differentially Fermented by the Canine and Feline Microbiome As Assessed in a Novel In VitroColonic Fermentation Model
97. A Bacteriophage Cocktail Eliminates Salmonella Typhimurium from the Human Colonic Microbiome while Preserving Cytokine Signaling and Preventing Attachment to and Invasion of Human Cells by Salmonella In Vitro.
98. Arabinoxylans, inulin and Lactobacillus reuteri 1063 repress the adherent-invasive Escherichia coli from mucus in a mucosa-comprising gut model
99. Arriving on time: Estimating travel time distributions on large-scale road networks
100. Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.